Jailed terror accused eat biryani for yrs, need fast-track courts: Chouhan

Mangaluru, Jul 26: Rubbishing reports about cancellation of institutional quarantine for international passengers in Mangaluru, local health authorities have clarified that 14 day isolation including first seven day institutional quarantine must for international passengers. 

For past couple of days rumours were doing rounds on social media that the government has done away with quarantine for international passengers. A few Mangaluru-based news portals also had published it as news without quoting any reliable sources. 

Meanwhile, district health officer in his clarification message said that neither Karnataka government nor Dakshina Kannada district administrant has revised the quarantine norms for international passengers. 

“Those who arrive from overseas must remain in isolation for 14 days. Out of this, seven days have to be spent in institutional quarantine (in hotel or lodge). During this period, the throat swab sample of the person will be sent for covid-19 testing. If the report is negative, then they will be sent to home quarantine for another seven days."

He said that concession in terms of number of days has only been given for people with other health conditions, children and the elderly. "For children below 10 years, pregnant women, elderly above the age of 60 years and other with other ailments, the throat swab will be collected on the second day of institutional quarantine. If the report turns negative, they will be sent to home quarantine for 14 days."

Mangaluru, Mar 27: In a shocking development, an infant with no travel history tests positive for the deadly novel coronavirus in Dakshina Kannada, taking the total coronavirus positive cases to six. 

The 10-month-old child, hailing from Sajipanadu Village in Bantwal Taluk was admitted to a hospital at Deralakatte in Mangaluru for treatment on March 23 as it had developed respiratory problems. 

On March 24, the child’s condition worsened and hence his throat swabs was sent for COVID-19 testing. Today, reports of the tests confirmed that the child was infected with COVID-19.

Pune/Bengaluru, Mar 25: e-Zest Solutions and Neurosynaptic Communications today announced the ReMeDi SCAN-CORONA platform, an innovative technology solution to help control the Novel COVID-19 pandemic.
As countries worldwide grapple to contain the spread and flatten the curve while treating the ones infected, the need of the hour is to deploy widespread screening and testing procedures to identify and isolate those showing symptoms.
The ReMeDi® SCAN-CORONA platform has a three-pronged approach to controlling the pandemic that makes the task of screening, testing, tracking and reporting extremely easy and manageable at a large scale.
"Mass screening and testing is the need of the hour. With the scarcity of healthcare professionals, there is a need of technology enabled platforms to do this at a large scale with minimal to no human intervention. The ReMeDi SCAN-CORONA brings together remote healthcare expertise and the power of emerging technology such as AI & ML, and promises to reduce the load on the healthcare system, so that timely care reaches the right set of people as fast as possible," said Shree Shingane - Founder and Managing Director, e-Zest Solutions GmbH.
The solution features a Corona-Screen Kit - a portable, lightweight kit that includes basic screening tools that seamlessly connect and feed data into a Patient Health Record (PHR) system without any manual intervention.
It also features a geo-tagging powered Screening app that, by importing and analyzing data from the screening tools as well as travel and medical history. The input from a third-party COVID-19 rapid testing kit further enhances the accuracy of the outcome.
"ReMeDi SCAN-CORONA helps front-line health workers to quickly assess the essential risk factors for a person digitally. It has the unique ability to track the progression of symptoms with time. The tele-consultation facility allows individuals to obtain counselling as well as consult doctors independent of location, to access timely information and guidance. We are proud to present this solution in collaboration with e-Zest," said Sameer Sawarkar CEO - Neurosynaptic.
The beauty of this solution is that while it can bring a big relief for COVID-19 screening efforts, it is equally advantageous to heavily burdened Healthcare Providers in remotely treating the non-corona health requirements as well.
The team acknowledges the valuable contribution in terms of clinical inputs for application development, from Dr Nandakumar, a renowned public health expert.
"e-Zest vision is to leverage Healthcare technologies to impact human life positively. We are happy to be part of this collaboration & look forward to it's contribution to combat the pandemic challenge globally," said Devendra Deshmukh, e-Zest CEO.
This story is provided by BusinessWire India. ANI will not be responsible in any way for the content of this article.